Twist Bioscience Equity 2024

Twist Bioscience Aktienanalyse

What does Twist Bioscience do?

Twist Bioscience Corp is a company specializing in the production and applications of synthetic DNA. It was founded in 2013 and is based in San Francisco, California, USA. The company utilizes proprietary technologies to cost-effectively produce high-quality and high-quantity synthetic DNA. The company operates in three business areas: DNA synthesis, biopharmaceuticals, and data storage. The DNA synthesis division is the core of the company and involves the production of synthetic DNA for applications in various industries, including medicine, agricultural science, biotechnology, plastic engineering, and others. The company manufactures customized DNA synthesis products tailored to the needs of its customers, allowing them to accelerate and optimize their research and development projects. Twist Bioscience has also developed a proprietary technology called "Twist Biosensor" that enables rapid and cost-effective analysis of genetic variations. The biopharmaceutical division focuses on the development of therapeutics and diagnostics based on synthetic DNA. Twist Bioscience develops antibodies and proteins that can be used in cancer and immunotherapy, as well as diagnostics. In the data storage field, Twist Bioscience develops solutions for storing large amounts of data on DNA. This technology utilizes the dense and stable structure of DNA to securely and reliably store data in the long term. Twist Bioscience's DNA synthesis products are utilized by researchers, companies, and public institutions in various industries. Customers value not only the wide product portfolio but also the high quality and precision of the products, as well as the speed of order processing. The company operates a number of manufacturing facilities near its customers in Europe and Asia to ensure fast and efficient delivery of its products. This allows Twist Bioscience to have a strong position in the global market. In recent years, the company has achieved significant milestones. In 2018, Twist Bioscience went public and raised a total of $70 million through its IPO. The company has also established partnerships with various other companies and institutions to develop new applications and products. Overall, Twist Bioscience is a growing company specializing in the production and applications of synthetic DNA. With its wide range of high-quality and customized DNA synthesis products, as well as its innovative solutions in the biopharmaceutical and data storage sectors, the company has established a strong market position. Twist Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Twist Bioscience's Equity

Twist Bioscience's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Twist Bioscience's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Twist Bioscience's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Twist Bioscience's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Twist Bioscience’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Twist Bioscience Stock

What is the equity of Twist Bioscience this year?

Twist Bioscience has equity of 623.4 M USD this year.

What was the equity of Twist Bioscience compared to the previous year?

The equity of Twist Bioscience has increased/decreased by -21.03% decreased compared to the previous year.

What impact does a high equity have on investors of Twist Bioscience?

A high equity is advantageous for investors of Twist Bioscience as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Twist Bioscience?

A low equity can be a risk for investors of Twist Bioscience, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Twist Bioscience affect the company?

An increase in equity of Twist Bioscience can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Twist Bioscience affect the company?

A reduction in equity of Twist Bioscience can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Twist Bioscience?

Some factors that can affect the equity of Twist Bioscience include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Twist Bioscience so important for investors?

The equity of Twist Bioscience is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Twist Bioscience take to change the equity?

To change equity, Twist Bioscience can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Twist Bioscience pay?

Over the past 12 months, Twist Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Twist Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Twist Bioscience?

The current dividend yield of Twist Bioscience is .

When does Twist Bioscience pay dividends?

Twist Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Twist Bioscience?

Twist Bioscience paid dividends every year for the past 0 years.

What is the dividend of Twist Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Twist Bioscience located?

Twist Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Twist Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Twist Bioscience from 5/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/15/2024.

When did Twist Bioscience pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Twist Bioscience in the year 2023?

In the year 2023, Twist Bioscience distributed 0 USD as dividends.

In which currency does Twist Bioscience pay out the dividend?

The dividends of Twist Bioscience are distributed in USD.